How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from …
RFE Pedretti, D Hansen, M Ambrosetti… - European journal of …, 2023 - academic.oup.com
A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal
patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for …
patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for …
Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type …
D Mahtta, DJ Ramsey, MT Lee, L Chen… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE There is mounting evidence regarding the cardiovascular benefits of sodium–
glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists …
glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists …
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction
In clinical practice, many patients with heart failure with reduced ejection fraction (HFrEF)
are either not prescribed guideline-directed medical therapies for which they are eligible or …
are either not prescribed guideline-directed medical therapies for which they are eligible or …
Epidemiology and risk factors for stroke in young individuals: implications for prevention
A Hussain, M Lee, J Rana… - Current opinion in …, 2021 - journals.lww.com
Among young patients, time-critical diagnosis and management remain challenging, due to
atypical stroke presentations, vast etiologies, statin hesitancy, and provider clinical inertia …
atypical stroke presentations, vast etiologies, statin hesitancy, and provider clinical inertia …
Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990–2017: a cohort study
Background Type 2 diabetes mellitus (T2DM) disproportionately affects individuals of
nonwhite ethnic origin. Timely and appropriate initiation and intensification of glucose …
nonwhite ethnic origin. Timely and appropriate initiation and intensification of glucose …
Gaps and disparities in primary prevention statin prescription during outpatient care
G Metser, C Bradley, N Moise, N Liyanage-Don… - The American journal of …, 2021 - Elsevier
The 2018 American College of Cardiology/American Heart Association Guideline on the
Management of Blood Cholesterol recommends statin therapy for eligible patients to reduce …
Management of Blood Cholesterol recommends statin therapy for eligible patients to reduce …
Evaluation of aspirin and statin therapy use and adherence in patients with premature atherosclerotic cardiovascular disease
Importance Studies on the use of and adherence to secondary prevention therapies in
patients with premature and extremely premature atherosclerotic cardiovascular disease …
patients with premature and extremely premature atherosclerotic cardiovascular disease …
Impact of different doses of omega-3 fatty acids on cardiovascular outcomes: a pairwise and network meta-analysis
M Lombardi, JG Chiabrando, GM Vescovo… - Current Atherosclerosis …, 2020 - Springer
Abstract Purpose of Review Omega-3 fatty acid (O3FA) supplementation has shown
conflicting evidence regarding its benefit in cardiovascular events. We performed a pairwise …
conflicting evidence regarding its benefit in cardiovascular events. We performed a pairwise …
Highlights of cardiovascular disease prevention studies presented at the 2022 American Heart Association Scientific Sessions
Abstract Purpose of Review Summarize selected late-breaking science on cardiovascular
(CV) disease prevention presented at the 2022 scientific session of the American Heart …
(CV) disease prevention presented at the 2022 scientific session of the American Heart …
Medication non-adherence and therapeutic inertia independently contribute to poor disease control for cardiometabolic diseases
X Yan, S Mudiganti, H Husby, A Hudnut, M Gbotoe… - Scientific Reports, 2022 - nature.com
Poorly controlled cardiometabolic biometric health gap measures [eg, uncontrolled blood
pressure (BP), HbA1c, and low-density lipoprotein cholesterol (LDL-C)] are mediated by …
pressure (BP), HbA1c, and low-density lipoprotein cholesterol (LDL-C)] are mediated by …